Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

ADAM10 as a biomarker for Alzheimer's disease: a study with Brazilian elderly.

Manzine PR, de França Bram JM, Barham EJ, do Vale Fde A, Selistre-de-Araújo HS, Cominetti MR, Iost Pavarini SC.

Dement Geriatr Cogn Disord. 2013;35(1-2):58-66. doi: 10.1159/000345983. Epub 2013 Jan 9.

PMID:
23306532
2.

Platelet a disintegrin and metallopeptidase 10 expression correlates with clock drawing test scores in Alzheimer's disease.

Manzine PR, Barham EJ, Vale FA, Selistre-de-Araújo HS, Pavarini SC, Cominetti MR.

Int J Geriatr Psychiatry. 2014 Apr;29(4):414-20. doi: 10.1002/gps.4020. Epub 2013 Aug 22.

PMID:
23970375
3.

Correlation between mini-mental state examination and platelet ADAM10 expression in Alzheimer's disease.

Manzine PR, Barham EJ, Vale Fde A, Selistre-de-Araújo HS, Iost Pavarini SC, Cominetti MR.

J Alzheimers Dis. 2013;36(2):253-60. doi: 10.3233/JAD-130125.

PMID:
23579328
4.

ADAM10 gene expression in the blood cells of Alzheimer's disease patients and mild cognitive impairment subjects.

Manzine PR, Marcello E, Borroni B, Kamphuis W, Hol E, Padovani A, Nascimento CC, de Godoy Bueno P, Assis Carvalho Vale F, Iost Pavarini SC, Di Luca M, Cominetti MR.

Biomarkers. 2015;20(3):196-201. doi: 10.3109/1354750X.2015.1062554. Epub 2015 Aug 4.

PMID:
26220620
5.

S100A7, a novel Alzheimer's disease biomarker with non-amyloidogenic alpha-secretase activity acts via selective promotion of ADAM-10.

Qin W, Ho L, Wang J, Peskind E, Pasinetti GM.

PLoS One. 2009;4(1):e4183. doi: 10.1371/journal.pone.0004183. Epub 2009 Jan 13.

6.

[alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients.

Colciaghi F, Borroni B, Pastorino L, Marcello E, Zimmermann M, Cattabeni F, Padovani A, Di Luca M.

Mol Med. 2002 Feb;8(2):67-74.

7.

Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease.

Tang K, Hynan LS, Baskin F, Rosenberg RN.

J Neurol Sci. 2006 Jan 15;240(1-2):53-8. Epub 2005 Oct 26.

8.

Serotoninergic antidepressants positively affect platelet ADAM10 expression in patients with Alzheimer's disease.

Bianco OA, Manzine PR, Nascimento CM, Vale FA, Pavarini SC, Cominetti MR.

Int Psychogeriatr. 2016 Jun;28(6):939-44. doi: 10.1017/S1041610215001842. Epub 2015 Nov 11.

PMID:
26555131
9.

Increase of α-Secretase ADAM10 in Platelets Along Cognitively Healthy Aging.

Schuck F, Wolf D, Fellgiebel A, Endres K.

J Alzheimers Dis. 2016;50(3):817-26. doi: 10.3233/JAD-150737.

PMID:
26757187
10.

Processing of the platelet amyloid precursor protein in the mild cognitive impairment (MCI).

Bermejo-Bescós P, Martín-Aragón S, Jiménez-Aliaga K, Benedí J, Felici E, Gil P, Ribera JM, Villar AM.

Neurochem Res. 2013 Jul;38(7):1415-23. doi: 10.1007/s11064-013-1039-7. Epub 2013 Apr 11.

PMID:
23575575
11.

Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease.

Colciaghi F, Marcello E, Borroni B, Zimmermann M, Caltagirone C, Cattabeni F, Padovani A, Di Luca M.

Neurology. 2004 Feb 10;62(3):498-501.

PMID:
14872043
12.

Abnormal platelet amyloid-β protein precursor (AβPP) metabolism in Alzheimer's disease: identification and characterization of a new AβPP isoform as potential biomarker.

Jelic V, Hagman G, Yamamoto NG, Teranishi Y, Nishimura T, Winblad B, Pavlov PF.

J Alzheimers Dis. 2013;35(2):285-95. doi: 10.3233/JAD-122122.

PMID:
23388171
13.

An enzyme-generated fragment of tau measured in serum shows an inverse correlation to cognitive function.

Henriksen K, Wang Y, Sørensen MG, Barascuk N, Suhy J, Pedersen JT, Duffin KL, Dean RA, Pajak M, Christiansen C, Zheng Q, Karsdal MA.

PLoS One. 2013 May 22;8(5):e64990. doi: 10.1371/journal.pone.0064990. Print 2013.

14.

Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's disease.

Reinhardt S, Schuck F, Grösgen S, Riemenschneider M, Hartmann T, Postina R, Grimm M, Endres K.

FASEB J. 2014 Feb;28(2):978-97. doi: 10.1096/fj.13-234864. Epub 2013 Oct 28.

PMID:
24165480
15.

Can platelet BACE1 levels be used as a biomarker for Alzheimer's disease? Proof-of-concept study.

Decourt B, Walker A, Gonzales A, Malek-Ahmadi M, Liesback C, Davis KJ, Belden CM, Jacobson SA, Sabbagh MN.

Platelets. 2013;24(3):235-8. doi: 10.3109/09537104.2012.688899. Epub 2012 Jul 9.

16.

Evidence against a role for rare ADAM10 mutations in sporadic Alzheimer disease.

Cai G, Atzmon G, Naj AC, Beecham GW, Barzilai N, Haines JL, Sano M, Pericak-Vance M, Buxbaum JD.

Neurobiol Aging. 2012 Feb;33(2):416-417.e3. doi: 10.1016/j.neurobiolaging.2010.03.003. Epub 2010 Apr 9.

17.

Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity.

Kim M, Suh J, Romano D, Truong MH, Mullin K, Hooli B, Norton D, Tesco G, Elliott K, Wagner SL, Moir RD, Becker KD, Tanzi RE.

Hum Mol Genet. 2009 Oct 15;18(20):3987-96. doi: 10.1093/hmg/ddp323. Epub 2009 Jul 15.

18.

Platelet immunoglobulin and amyloid precursor protein as potential peripheral biomarkers for Alzheimer's disease: findings from a pilot study.

Mukaetova-Ladinska EB, Abdel-All Z, Dodds S, Andrade J, Alves da Silva J, Kalaria RN, O'Brien JT.

Age Ageing. 2012 May;41(3):408-12. doi: 10.1093/ageing/afr171. Epub 2012 Jan 17.

PMID:
22258116
19.

Genetic association between ADAM10 gene polymorphism and Alzheimer's disease in a Northern Han Chinese population.

Song JH, Yu JT, Liu M, Yan CZ, Tan L.

Brain Res. 2011 Nov 3;1421:78-81. doi: 10.1016/j.brainres.2011.09.008. Epub 2011 Sep 14.

PMID:
21959176
20.

Endocytosis of synaptic ADAM10 in neuronal plasticity and Alzheimer's disease.

Marcello E, Saraceno C, Musardo S, Vara H, de la Fuente AG, Pelucchi S, Di Marino D, Borroni B, Tramontano A, Pérez-Otaño I, Padovani A, Giustetto M, Gardoni F, Di Luca M.

J Clin Invest. 2013 Jun;123(6):2523-38. doi: 10.1172/JCI65401. Epub 2013 May 8.

Supplemental Content

Support Center